Table of Content

Chapter 1 Introduction
Introduction
Study Goals and Objectives
Reasons for Doing the Study
Intended Audience
Scope and Format
Methodology
Market Estimates
Information Sources
Geographical Breakdown
Analyst’s Credentials

Chapter 2 Summary and Highlights

Chapter 3 Overview
Homologous Recombination (HR)
Targets for Cancer Therapy

Chapter 4 Impact of COVID-19 Pandemic

Chapter 5 Market Dynamics
Market Drivers
Increasing Incidences of Chronic Diseases
Growing Aging Population
Advancements in Manufacturing Technologies
Market Restraints
Price Controls
Entry of Biosimilars
Opportunities
Untapped Potential in Emerging Markets

Chapter 6 Market Breakdown by Product Type
Human Protein Replacements
Market Size and Forecast
Therapeutic Agents for Human Diseases
Market Size and Forecast
Vaccines
Types of Vaccines
Market Size and Forecast

Chapter 7 Market Breakdown by End User
Biotechnology and Pharmaceutical Industry
Market Size and Forecast
Research Laboratories and Academic Institutes
Market Size and Forecast

Chapter 8 Market Breakdown by Region
Global Market by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 9 Competitive Landscape
Overview

Chapter 10 Company Profiles
ABBVIE INC.
ALEXION PHARMACEUTICALS
AMGEN INC.
ELI LILLY
MERCK & CO. INC.
SANOFI S.A.
TAKEDA PHARMACEUTICAL CO LTD.



List of Figures


Summary Figure A : Global Market for Human Recombinant DNA, by Region, 2020–2027
Summary Figure B : Global Market Shares of Human Recombinant DNA, by Region, 2021
Figure 1 : Global Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 2 : Global Market for Human Recombinant DNA, by Product Type, 2020–2027
Figure 3 : Global Market for Human Protein Replacements, 2020–2027
Figure 4 : Global Market for Therapeutic Agents for Human Diseases, 2020–2027
Figure 5 : Evolution of Vaccine Technologies
Figure 6 : Global Market for Vaccines, 2020-2027
Figure 7 : Global Market Shares of Human Recombinant DNA, by End User, 2021
Figure 8 : Global Market for Human Recombinant DNA, by End User, 2020–2027
Figure 9 : Global Market for Human Recombinant DNA in the Biotechnology and Pharmaceutical Industry, 2020–2027
Figure 10 : Global Market for Human Recombinant DNA in Research Laboratories and Academic Institutes, 2020–2027
Figure 11 : Global Market Shares of Human Recombinant DNA, by Region, 2021
Figure 12 : North American Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 13 : North American Market Shares of Human Recombinant DNA, by End User, 2021
Figure 14 : North American Market Shares of Human Recombinant DNA, by Country, 2021
Figure 15 : U.S. Market for Human Recombinant DNA, 2020–2027
Figure 16 : Canadian Market for Human Recombinant DNA, 2020–2027
Figure 17 : European Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 18 : European Human Recombinant DNA Market, Market Shares, by End User, 2021
Figure 19 : European Market Shares of Human Recombinant DNA, by Country, 2021
Figure 20 : Geriatric Population in Germany, 2000-2030
Figure 21 : German Market for Human Recombinant DNA, 2020–2027
Figure 22 : U.K. Market for Human Recombinant DNA, 2020–2027
Figure 23 : French Market for Human Recombinant DNA, 2020–2027
Figure 24 : Italian Market for Human Recombinant DNA, 2020–2027
Figure 25 : Spanish Market for Human Recombinant DNA, 2020–2027
Figure 26 : Rest of Europe Market for Human Recombinant DNA, 2020–2027
Figure 27 : Asia-Pacific Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 28 : Asia-Pacific Human Recombinant DNA Market, Market Shares, by End User, 2021
Figure 29 : Asia-Pacific Market Shares of Human Recombinant DNA, by Country, 2021
Figure 30 : New Cancer Cases in China, 2020
Figure 31 : Distribution of New Cancer Cases in China, 2020
Figure 32 : Chinese Market for Human Recombinant DNA, 2020-2027
Figure 33 : Japanese Market for Human Recombinant DNA, 2020-2027
Figure 34 : Indian Market for Human Recombinant DNA, 2020–2027
Figure 35 : Rest of Asia-Pacific Market for Human Recombinant DNA, 2020–2027
Figure 36 : New Cancer Cases in Africa, 2020
Figure 37 : RoW Market Shares of Human Recombinant DNA, by Product Type, 2021
Figure 38 : RoW Market Shares of Human Recombinant DNA, by End User, 2021
Figure 39 : AbbVie Inc.: Net Revenue, by Business Segment, 2020
Figure 40 : AbbVie Inc.: Net Revenue, by Region, 2020
Figure 41 : Amgen: Total Sales, by Product, 2020
Figure 42 : Amgen: Total Revenue, by Region, 2020
Figure 43 : Eli Lilly: Total Sales, by Product Segment, 2020
Figure 44 : Eli Lilly: Total Revenue, by Region, 2020
Figure 45 : Sanofi: Net Sales, by Business Segment, 2020
Figure 46 : Sanofi: Net Sales, by Region, 2020

List of Tables


Summary Table : Global Market for Human Recombinant DNA, by Region, Through 2027
Table 1 : Estimated World Population and Annual Growth, by Selected Age Group, Through 2030
Table 2 : Cancer Statistics Across Major Asian Countries, by Cancer Site/Type, 2020
Table 3 : Global Human Recombinant DNA Market, by Product Type, Through 2027
Table 4 : Global Market for Human Protein Replacements, by Region, Through 2027
Table 5 : Global Market for Therapeutic Agents for Human Diseases, by Region, Through 2027
Table 6 : Vaccine Types
Table 7 : Global Market for Vaccines, by Region, Through 2027
Table 8 : Global Market for Human Recombinant DNA, by End User, Through 2027
Table 9 : Global Market for Human Recombinant DNA in the Biotechnology and Pharmaceutical Industry, by Region, Through 2027
Table 10 : Global Market for Human Recombinant DNA in Research Laboratories and Academic Institutes, by Region, Through 2027
Table 11 : Global Market for Human Recombinant DNA, by Region, Through 2027
Table 12 : North American Market for Human Recombinant DNA, by Product Type Through 2027
Table 13 : North American Market for Human Recombinant DNA, by End User, Through 2027
Table 14 : North American Market for Human Recombinant DNA, by Country, Through 2027
Table 15 : European Market for Human Recombinant DNA, by Product Type, Through 2027
Table 16 : European Human Recombinant DNA Market, by End User, Through 2027
Table 17 : European Market for Human Recombinant DNA, by Country, Through 2027
Table 18 : Asia-Pacific Market for Human Recombinant DNA, by Product Type, Through 2027
Table 19 : Asia-Pacific Human Recombinant DNA Market, by End User, Through 2027
Table 20 : Asia-Pacific Market for Human Recombinant DNA, by Country, Through 2027
Table 21 : Japan: Total Number of New Cancer Cases in Both Genders, 2020
Table 22 : RoW Market for Human Recombinant DNA, by Product Type, Through 2027
Table 23 : RoW Market for Human Recombinant DNA, by End User, Through 2027
Table 24 : Leading Market Players in the Human Recombinant DNA Market Ecosystem
Table 25 : AbbVie Inc.: Business Segments
Table 26 : AbbVie Inc.: Financial Performance, Through 2020
Table 27 : Amgen: Financial Performance, Through 2020
Table 28 : Eli Lilly: Business Segments
Table 29 : Eli Lilly: Financial Performance, 2018-2020
Table 30 : Sanofi: Business Segments
Table 31 : Sanofi: Financial Performance, 2018-2020